Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Current status of production and market of human vaccine products in Korea.

Kim SY, Cho J, Cha SH, Bae CW.

Clin Exp Vaccine Res. 2013 Jul;2(2):120-7. doi: 10.7774/cevr.2013.2.2.120. Epub 2013 Jul 3.

2.
3.

[An analysis of the pharmaceuticals market in Vietnam].

Simonet D.

Sante. 2001 Jul-Sep;11(3):155-60. French.

PMID:
11641078
4.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
5.

The potential global market size and public health value of an HIV-1 vaccine in a complex global market.

Marzetta CA, Lee SS, Wrobel SJ, Singh KJ, Russell N, Esparza J.

Vaccine. 2010 Jul 5;28(30):4786-97. doi: 10.1016/j.vaccine.2010.04.098. Epub 2010 May 14.

PMID:
20471439
6.

[Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].

Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, Kang HY.

J Prev Med Public Health. 2009 Jul;42(4):251-60. doi: 10.3961/jpmph.2009.42.4.251. Korean.

7.

National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea.

Yi H, Ha YC, Lee YK, Lim YT.

J Bone Metab. 2013 May;20(1):17-23. doi: 10.11005/jbm.2013.20.1.17. Epub 2013 May 13.

9.

When medicine becomes a disease.

[No authors listed]

Arabia. 1986 Mar;5(55):32-6.

PMID:
12340711
10.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Review.

11.
13.

The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.

Shen AK.

Hum Vaccin. 2009 Oct;5(10):649-53. Epub 2009 Oct 7.

PMID:
19713758
14.

[The socioeconomic cost of injuries in South Korea].

Park K, Lee JS, Kim Y, Kim YI, Kim J.

J Prev Med Public Health. 2009 Jan;42(1):5-11. doi: 10.3961/jpmph.2009.42.1.5. Korean.

15.

China's emerging vaccine industry.

Hendriks J, Liang Y, Zeng B.

Hum Vaccin. 2010 Jul;6(7):602-7. Epub 2010 Jul 1.

PMID:
20523120
16.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

17.

The world ginseng market and the ginseng (Korea).

Baeg IH, So SH.

J Ginseng Res. 2013 Mar;37(1):1-7. doi: 10.5142/jgr.2013.37.1.

18.

A fresh injection of interest for vaccines.

[No authors listed]

AIDS Anal Afr. 1998 Feb;8(1):3, 6.

PMID:
12293289
19.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
20.
Items per page

Supplemental Content

Write to the Help Desk